Background
==========

Stroke causes about 11% of all death across the world and is the most common cause of adult-acquired disability \[[@b1-medscimonit-21-3658]\]. Ischemic stroke (IS) and intracerebral hemorrhage (ICH) constitute about 80--85% and 15--20% of all stroke cases, respectively \[[@b1-medscimonit-21-3658]\]. IS is a highly complex disease caused by multiple genetic and environmental risk factors \[[@b2-medscimonit-21-3658]\]. Several susceptible genes associated with increased risk of IS have been recognized, such as ACE, F5, MTHFR, and APOE \[[@b3-medscimonit-21-3658]\]. But these findings only revealed a part of the inherited risk of IS. It is necessary to further study the genetic background and disease susceptibility genes to better understand this disease.

MicroRNAs (miRNAs) are a group of small (\~22-nucleotide) and conserved endogenous non-coding RNA. They can bind to the 3′-untranslated region (3′-UTR) of target mRNAs, thereby regulating gene expression through translational repression or mRNA degradation \[[@b4-medscimonit-21-3658]\]. Single-nucleotide polymorphisms (SNPs) were the most frequent variation in the human genome. SNPs or mutations in mature miRNAs may affect the maturation process or target selection, thus influencing the downstream physiological processes \[[@b5-medscimonit-21-3658],[@b6-medscimonit-21-3658]\]. Three well-known SNPs in pre-miRNA sequences -- miR-146a C/G (rs2910164), miR-196a2 T/C (rs11614913), and miR-499 A/G (rs3746444) -- have been widely studied and were associated with the risk of several diseases \[[@b7-medscimonit-21-3658],[@b8-medscimonit-21-3658]\]. In fact, miR-146a is closely related to regulation of tumor necrosis factor-α (TNF-α) \[[@b9-medscimonit-21-3658]\]. MiR-146a were significantly downregulated in patients with IS in the acute phase but upregulated in the subacute phase \[[@b10-medscimonit-21-3658]\], exerting a neuroprotective effect through astrocytes \[[@b11-medscimonit-21-3658]\]. MiR-196a2 can target annexin A1 \[[@b12-medscimonit-21-3658]\]. MiR-499 can affect the inflammatory reaction through modulating C-reactive protein (CRP) \[[@b13-medscimonit-21-3658]\]. Therefore, these 3 miRNAs may play important roles in regulating thrombosis or inflammation pathways in the circulation system. Considering the important role of the SNPs in the expression or targeting of the miRNAs, several recent studies tried to explore the influence of the SNPs on IS risk \[[@b14-medscimonit-21-3658]--[@b17-medscimonit-21-3658]\]. However, the results were conflicting and inconclusive. The present meta-analysis aimed to pool previous studies to get a more precise assessment of the association between the 3 SNPs and the risk of IS.

Material and Methods
====================

Searching strategy
------------------

Relevant studies published before 1 June 2015 were systematically searched by 2 authors independently in the databases, including PubMed, Embase, Chinese National Knowledge Infrastructure (CNKI), and Chinese Biomedical Literature Database (CBLM) by using the following searching terms: "ischemic stroke (IS)" and ("single nucleotide polymorphism" or "polymorphism" or "mutation" or "variant" or "SNP") and ("microRNA" or "miRNA" or "miR"). No language restriction was applied for searching. Reference list of studies included and other relevant meta-analyses or reviews were manually searched to find other potentially qualified studies.

Studies meeting the following criteria were included in this meta-analysis: (1) Case-control design; (2) Studies assessed the association between SNP of miRNAs and the risk of IS; (3) the genotype distribution of the controls agreed with the Hardy-Weinberg equilibrium (HWE); (4) Detailed data of genotype frequency could be extracted from original studies. Repeat studies and studies without detailed data were excluded.

Data extraction
---------------

Two authors independently extracted data from the original studies. The information extracted included surname of the first author, year of publication, country, ethnicity, disease, numbers of subjects, age, sex, source of controls, genotyping methods, genotype frequency of case and control, and p value of Hardy-Weinberg equilibrium (HWE) in controls. Disagreement was resolved by referring to original studies in group discussion.

Quality assessment of studies included
--------------------------------------

The quality of included studies was assessed using the modified Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) quality score system. This system has 40 assessment items to assess a trial's quality by giving scores from 0 to 40. Based on the scoring, the quality is defined as low quality (0--19), moderate quality (20--29), or high quality (30--40).

Statistical analysis
--------------------

Cochrane Review Manager (version 5.3, Cochrane Collaboration, Copenhagen, Denmark) was used for data integration and analysis. The χ^2^ test was used to evaluate the HWE of the control group. The strength of the association between the SNPs and IS were estimated by pooling odds ratios (OR) and 95% confidence intervals (CI) under 5 genetic models, including allele model, homozygote model, heterozygote model, dominant model, and recessive model. Statistical heterogeneity among studies was assessed using the chi square-based Q test and I^2^ \[[@b12-medscimonit-21-3658]\]. χ^2^ tests p\<0.1 or I^2^ \>50% indicates significant heterogeneity \[[@b12-medscimonit-21-3658]\]. If there was significant heterogeneity among the studies, the random-effects model (the DerSimonian and Laird method) was used to make estimates, otherwise the fixed-effects model (Mantel-Haenszel method) was used. Since only 5 original studies were involved, there was no need to assess the publication bias. The statistical significance of the pooled OR was determined by Z test and p\<0.05 was considered as a significant difference.

Results
=======

Characteristics of studies included
-----------------------------------

A total of 8 studies were found through searching in the databases. Among them, 2 were excluded for irrelevance and 1 meta-analysis was excluded. Finally, 5 studies meeting the criteria were included \[[@b14-medscimonit-21-3658]--[@b18-medscimonit-21-3658]\], among which 2254 cases and 2506 controls were included. The flow chart summarizing the search process is shown in [Figure 1](#f1-medscimonit-21-3658){ref-type="fig"} and the basic information of the included studies is given in [Table 1](#t1-medscimonit-21-3658){ref-type="table"}. Among the 5 studies, 5 assessed the association between miR-146a (rs2910164) and IS risks, 4 assessed miR-196a2 (rs11614913), and 3 assessed miR-499 (rs3746444). The genotype distribution of rs2910164, rs11614913, and rs3746444 is presented in [Table 2](#t2-medscimonit-21-3658){ref-type="table"}. All of the studies had genotype distribution in controls in agreement with Hardy-Weinberg equilibrium (HWE) expectation.

Results of meta-analysis
------------------------

The results of meta-analysis for the association between the 3 SNPs (rs2910164, rs11614913, and rs3746444) and the IS risks are shown in [Table 3](#t3-medscimonit-21-3658){ref-type="table"}.

MiR-146a rs2910164 C/G and the risk of IS
-----------------------------------------

There was no significant association between this SNP and the IS risk under all genetic models. When performing a subgroup analysis by country, a similar trend was observed in the Chinese population. However, significant associations were observed in the Korean population under the allele model (OR=0.81, 95% CI=0.68--0.95, p=0.009), dominant model (OR=0.68, 95% CI=0.50--0.93, p=0.02), recessive model (OR=0.79, 95% CI=0.63--1.00, p=0.05), and homozygous model (OR=0.63, 95%CI=0.45--0.88, p=0.007) ([Table 3](#t3-medscimonit-21-3658){ref-type="table"}), suggesting there might be some protective effect of the C allele in Koreans.

MiR-196a2 rs11614913 T/C and the risk of IS
-------------------------------------------

For rs11614913, a significant association between T allele and increased IS risk was observed under the dominant model (OR=1.35, 95% CI=1.15--1.59, p=0.0003), but not under other models. Subgroup analysis showed this association was only significant in Chinese (OR=1.45, 95% CI=1.19--1.78, p=0.0003), but not in Koreans ([Table 3](#t3-medscimonit-21-3658){ref-type="table"}).

MiR-499 rs3746444 A/G and the risk of IS
----------------------------------------

For rs3746444, there was no significant association between this SNP and the IS risk under all genetic models, but subgroup analysis showed homozygote AA was associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23--0.98, p=0.04) ([Table 3](#t3-medscimonit-21-3658){ref-type="table"}) in Chinese.

Discussion
==========

In this study, we found that, although the 3 SNPs might be associated with IS, the association varied significantly in different countries. rs2910164 C allele was associated with lower IS risk, but this trend was only observed in Koreans under the allele model, dominant model, recessive model, and homozygous model. rs11614913 T allele might be associated with higher IS risk under the dominant model (OR=1.45, 95% CI=1.19--1.78, p=0.0003), while rs3746444 A allele might be associated with decreased IS risk under the homozygous model (OR=0.48, 95% CI=0.23--0.98, p=0.04) only in Chinese. These results suggest that the effect of the SNPs might be significantly related to genetic background of a population.

Some recent studies found some miRNAs are dysregulated in IS. For example, miR-497 can directly bind to the 3′UTR of B-cell lymphoma 2 (Bcl-2) and Bcl-w mRNAs, whose proteins play an important role in attenuating stroke-induced apoptotic cell death \[[@b19-medscimonit-21-3658]\]. MiR-29b expression was significantly increased in rat brains by focal ischemia. It can also directly bind to the Bcl-2 mRNA and thereby promote neuronal cell death \[[@b20-medscimonit-21-3658]\]. The miR-146a/rs2910164, miR-196a2/rs11614913, and miR-499/rs3746444 were all in the 3p strand of mature miRNA regions. The G allele of rs2910164 and T allele of rs11614913 are associated with decreased mature miRNA levels \[[@b21-medscimonit-21-3658],[@b22-medscimonit-21-3658]\]. This might help to explain why these 2 alleles were associated with increased risk of IS in Koreans and Chinese. In fact, miR-146a can regulate the expression of TNF-α and also inhibit the pro-inflammatory MAP kinase pathway and NF-κB pathway \[[@b23-medscimonit-21-3658]\], which are closely related to occurrence of IS. A recent study found stroke acutely activates the Toll-like receptor (TLR) signaling pathway in cerebral vasculature. Upregulation of miR-146a contributes to neuroprotection, partly through inactivation of the TLR signaling pathway \[[@b24-medscimonit-21-3658]\]. MiR-196a2 can regulate annexin A1, which has significant repressing effects on both neutrophil and monocyte migration and adhesion in atherosclerosis. Annexin A1, as an important endogenous anti-inflammatory mediator, can also repress the expression and activation of inflammatory enzymes, such as inducible cyclooxygenase 2 (COX2), inducible nitric oxide synthase (iNOS), and phospholipase A2 \[[@b25-medscimonit-21-3658]\]. Therefore, through regulating annexin A1, miR-196a2 might exert some effect in IS. MiR-499 can regulate CRP, a protein closely related to cerebral ischemia. In addition, mi-499 can also regulate cell apoptosis and cell death in anoxia and ischemia conditions by targeting calcineurin and dynamin-related protein-1 \[[@b26-medscimonit-21-3658]\]. Since rs3746444 A/G mutation might affect binding of targeting mRNAs and maturation of pre-miRNA, it is possible that this SNP might significantly affect downstream biological functions.

This study also has several limitations. Firstly, due to the limited number of original studies, the number of patients included was relatively small. After a comprehensive literature search, only 5 eligible studies were included. Secondly, the information on clinicopathological characteristics or disease subtypes was poorly provided in original studies, making it difficult to perform more subgroup meta-analysis. Thirdly, IS is a disease influenced by both genetic and environmental factors. The gene-gene and gene-environment interactions may significantly affect function of a single SNP. Therefore, the exact effect of the SNPs may vary in different populations with different genetic backgrounds. In addition, a SNP might be in linkage disequilibrium with other genetic variations of stroke susceptibility genes, which may present stronger effect when considered together with other variations. These hypotheses need to be tested in future studies.

Conclusions
===========

The current meta-analysis suggests that rs2910164 C allele might be associated with lower IS risk in Koreans. rs11614913 T allele might be associated with higher IS risk under the dominant model, while rs3746444 A allele might be associated with decreased IS risk under the homozygous model in Chinese. However, these findings should be further verified in studies with large sample sizes.

**Source of support:** Departmental sources
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###### 

The basic characteristics of studies included.

  Study        Country   Ethnicity   Disease   Source of control   No. participants   Age (mean ±SD)   Male, n (%)                                                       SNP                                                               Genotype method   Quality score                                                           
  ------------ --------- ----------- --------- ------------------- ------------------ ---------------- ----------------------------------------------------------------- ----------------------------------------------------------------- ----------------- --------------- -------------------------------------------- ---------- ----
  Sun 2011     China     Asian       IS        HB                  650                381              62 ±13                                                            63 ±12                                                            347 (53.4)        236 (61.9)      rs2910164                                    PCR-RFLP   30
  Jeon 2013    China     Asian       IS        HB                  553                678              63.14 ±10.19                                                      64.16 ±11.90                                                      244 (44.1)        336 (49.6)      rs2910164; rs2292832 rs11614913; rs3746444   Taqman     36
  Liu 2014     China     Asian       IS        HB                  391                296              66.34 ±11.07                                                      67.52 ±10.29                                                      227 (58.06)       180 (60.81)     rs2910164; rs11614913; rs3746444             PCR-RFLP   34
  Zhu 2014     China     Asian       IS        HB                  381                368              62.05 ±0.98                                                       61.62 ±0.97                                                       261 (68.50)       253 (68.75)     rs2910164; rs11614913                        PCR-LDR    33
  Huang 2015   China     Asian       IS        HB                  531                531              61 (54, 68)[\*](#tfn2-medscimonit-21-3658){ref-type="table-fn"}   63 (54, 70)[\*](#tfn2-medscimonit-21-3658){ref-type="table-fn"}   327 (61.6)        327 (61.6)      rs2910164; rs11614913; rs3746444             Taqman     34

IS -- ischemic stroke; HB -- hospital based; PCR-RELP -- polymerase chain reaction-restriction fragment length polymorphism; PCR-LDR -- polymerase chain reaction-ligation detection reaction; SNP -- single nucleotide polymorphism.

data are expressed as median (25^th^, 75^th^ quartiles).

###### 

The genotype distribution of rs2910164, rs11614913 and rs3746444.

  Study        miRNA       SNP              Control   Cases    P.HWE                               
  ------------ ----------- ---------------- --------- -------- -------- -------- -------- -------- -------
  Huang 2015   miR-146a    rs2910164 C/G    219       257      55       189      261      81       0.106
  Jeon 2013    miR-146a    rs2910164 C/G    211       266      76       223      327      128      0.589
  Liu 2014     miR-146a    rs2910164 C/G    116       198      77       85       159      52       0.650
  Sun 2011     miR-146a    rs2910164 C/G    228       304      118      146      170      65       0.345
  Zhu 2014     miR-146a    rs2910164 C/G    132       185      64       145      173      50       0.952
                                            **TT**    **TC**   **CC**   **TT**   **TC**   **CC**   
  Huang 2015   miR-196a2   rs11614913 T/C   153       266      112      166      265      100      0.856
  Jeon 2013    miR-196a2   rs11614913 T/C   156       292      105      187      352      139      0.126
  Liu 2014     miR-196a2   rs11614913 T/C   93        214      84       64       181      51       0.060
  Zhu 2014     miR-196a2   rs11614913 T/C   105       198      78       108      189      71       0.384
                                            **AA**    **AG**   **GG**   **AA**   **AG**   **GG**   
  Huang 2015   miR-499     rs3746444 A/G    403       128      0        398      133      0        0.002
  Jeon 2013    miR-499     rs3746444 A/G    365       170      18       460      195      23       0.740
  Liu 2014     miR-499     rs3746444 A/G    278       99       14       181      96       19       0.170

###### 

Overall and stratified analyses of association between the three SNPs and the IS risk.

  miRNAs and SNP                     No. studies   Cases/ controls   Genetic models                                                                                                                                                                                                                                                                                                                          
  ---------------------------------- ------------- ----------------- ---------------------------------- ----------------------------------------- ------------------------------------------ ---------------------------------------- ------------------------------------------ ---------- ------------------- ---------- ---------- ------------------- ----------- ---------- ------------------- ------- ----------
  Overall miR-146a rs2910164 C/G     5             2254/ 2506        0.96 (0.82--1.13)                  0.63                                      73%                                        0.92 (0.70--1.21)                        0.56                                       67%        0.96 (0.79--1.15)   0.64       57%        0.91 (0.64--1.28)   0.58        74%        0.96 (0.85--1.09)   0.57    17%
  China                              4             1576/ 1953        1.01 (0.85, 1.20)                  0.92                                      69%                                        1.00 (0.74, 1.35)                        1.00                                       62%        1.01 (0.82, 1.24)   0.93       54%        1.00 (0.69, 1.47)   0.98        70%        1.00 (0.87, 1.16)   0.96    18%
  Korea                              1             678/ 553          0.81 (0.68, 0.95)                  **0.009**                                 --                                         0.68 (0.50, 0.93)                        **0.02**                                   --         0.79 (0.63, 1.00)   **0.05**   --         0.63 (0.45, 0.88)   **0.007**   --         0.86 (0.67, 1.10)   0.23    --
                                                                     **T** *vs.* **C (allele model)**   **TT+TC** *vs.* **CC (dominant model)**   **TT** *vs.* **TC+CC (recessive model)**   **TT** *vs.* **CC (homozygous model)**   **TT** *vs.* **TC (heterozygous model)**                                                                                                                               
  **OR (95% CI)**                    **P**         **I^2^**          **OR (95% CI)**                    **P**                                     **I^2^**                                   **OR (95% CI)**                          **P**                                      **I^2^**   **OR (95% CI)**     **P**      **I^2^**   **OR (95% CI)**     **P**       **I^2^**                               
  Overall miR-196a2 rs11614913 T/C   4             1873/ 1856        1.03 (0.94--1.13)                  0.48                                      0%                                         1.35 (1.15--1.59)                        **0.0003**                                 0%         1.02 (0.89--1.18)   0.75       0%         1.07 (0.89--1.30)   0.46        0%         1.00 (0.86--1.17)   0.95    0%
  China                              3             1195/ 1303        1.07 (0.96, 1.20)                  0.22                                      0%                                         1.45 (1.19, 1.78)                        **0.0003**                                 0%         1.05 (0.88, 1.25)   0.58       0%         1.17 (0.93, 1.47)   0.19        0%         1.01 (0.84, 1.22)   0.91    0%
  Korea                              1             678/ 553          0.96 (0.82, 1.12)                  0.6                                       --                                         1.17 (0.88, 1.55)                        0.29                                       --         0.97 (0.75, 1.24)   0.81       --         0.91 (0.65, 1.26)   0.56        --         0.99 (0.76, 1.29)   0.97    --
                                                                     **A** *vs.* **G (allele model)**   **AA+AG** *vs.* **GG (dominant model)**   **AA** *vs.* **GG+AG (recessive model)**   **AA** *vs.* **GG (homozygous model)**   **AA** *vs.* **AG (heterozygous model)**                                                                                                                               
                                                                     **OR (95% CI)**                    **P**                                     **I^2^**                                   **OR (95% CI)**                          **P**                                      **I^2^**   **OR (95% CI)**     **P**      **I^2^**   **OR (95% CI)**     **P**       **I^2^**   **OR (95% CI)**     **P**   **I^2^**
  Overall miR-499 rs3746444 A/G      3             1505/ 1475        0.88 (0.67--1.16)                  0.38                                      73%                                        0.75 (0.47--1.19)                        0.22                                       29%        0.88 (0.66--1.19)   0.42       71%        0.70 (0.35--1.42)   0.33        54%        0.91 (0.69--1.19)   0.47    63%
  China                              2             827/ 922          0.80 (0.56, 1.14)                  0.22                                      73%                                        0.54 (0.27, 1.10)                        0.09                                       --         0.79 (0.53, 1.16)   0.22       70%        0.48 (0.23, 0.98)   **0.04**    --         0.81 (0.58, 1.14)   0.22    59%
  Korea                              1             678/ 553          1.06 (0.86, 1.30)                  0.59                                      --                                         0.96 (0.51, 1.79)                        0.89                                       --         1.09 (0.86, 1.38)   0.49       --         0.99 (0.52, 1.86)   0.97        --         1.10 (0.86, 1.41)   0.46    --

OR -- odds ratios; 95%CI -- 95% confidence interval; "--" -- not available. Bold indicates significant p values.
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